US20040054417A1 - Disposable articulated spacing device for surgical treatment of joints of the human body - Google Patents

Disposable articulated spacing device for surgical treatment of joints of the human body Download PDF

Info

Publication number
US20040054417A1
US20040054417A1 US10/239,813 US23981303A US2004054417A1 US 20040054417 A1 US20040054417 A1 US 20040054417A1 US 23981303 A US23981303 A US 23981303A US 2004054417 A1 US2004054417 A1 US 2004054417A1
Authority
US
United States
Prior art keywords
spacing device
joint
members
formed members
articulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/239,813
Inventor
Renzo Soffiati
Claudio Castelli
Giovanni Faccioli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecres SpA
Original Assignee
Tecres SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11461146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040054417(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tecres SpA filed Critical Tecres SpA
Assigned to TECRES S.P.A. reassignment TECRES S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CASTELLI, CLAUDIO, FACCIOLI,GIOVANNI, SOFFIATI, RENZO
Publication of US20040054417A1 publication Critical patent/US20040054417A1/en
Priority to US10/963,123 priority Critical patent/US7601176B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/38—Joints for elbows or knees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30672—Features concerning an interaction with the environment or a particular use of the prosthesis temporary
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body

Definitions

  • the present invention is generally applicable to surgical treatment of articulations of the human body and in particular relates to a disposable spacing device for temporary replacement of joint prosthesis which have to be explanted due to unsuccessful septic or aseptic implantation of artificial joints.
  • the above spacing device can be maintained in the joint seat as long as necessary for reestablishing the most favourable conditions of implantation of the new artificial joint prosthesis.
  • Italian patent application No. VR95A000072 describes a disposable spacing device for an artificial hip joint, essentially characterized in that it is made of a biocompatible base material of the type used for bone cements.
  • Spacing devices for knee joints which are manually made by the surgeon at the time of the surgical operation are also known, these devices being made from blocks of bone cement of standard shape, optionally containing active constituents.
  • a drawback of these known methods of treatment is that they do not allow the space within the joint to be kept apart in an ergonomically and anatomically correct manner. Moreover, the long time required for preparation increases the difficulties for the surgeon and reduces the probability of success of the operation.
  • spacing devices have been made using suitable anatomically and ergonomically shaped moulds which are filled with bone cement in situ.
  • these known spacing devices do not allow mobilisation of the joint and result in the need for a long rehabilitation after reimplanting the permanent prosthesis.
  • the spacing devices have been obtained by lining a permanent metal prosthesis with bone cement.
  • this solution allows a temporary articulation, it is difficult to prepare and in spite of use of cement-lined prostheses requires that such devices are positioned in infected seats, which most of the surgeon consider a worsening infection factor.
  • DE-A-29703971 discloses a temporary knee prosthesis comprising three pre-formed members made of bone cement and impregnated with an antibiotic agent, in accordance with the preamble of claim 1 .
  • the antibiotic agent is added to the bone cement forming the members during their formation process and therefore the pre-formed members are initially impregnated with such medicaments.
  • the surgeon has no freedom to choose the specific antibiotic or its amount which are more closely correlated to the particular patient.
  • the prosthesis which is not a pharmaceutical product must nevertheless be packaged and stored in a suitable manner to comply with the requirements of the parmaceutical products.
  • U.S. Pat. No. 5,980,573 relates to a temporary hip prosthesis comprising a single pre-formed member failing to provide a complete articulation joint.
  • the base material of the prosthesis is impregnated with an antibiotic agent by simply-mixing it in appropriate amount with the constituent elements of the material during the formation process of the member.
  • the pre-formed temporary prosthesis is pre-packaged in a sterile packet or container having indicia or colour coding indicating the size of the prosthesis contained therein and the antibiotic concentration, thereby excluding that impregnation is accomplished immediately prior of implantation.
  • EP-A-0811359 teaches a method for manufacturing a material adapted for use as base material for prostheses, which material is formed by a three dimensional structure of band pieces joined together with the interposition of intermediate removable materials to form adjustable hollow spaces.
  • the hollow spaces of the material may be filled with pharmaceutical or therapeutical active products such as antibiotics, hormones or growing agents.
  • active products such as antibiotics, hormones or growing agents.
  • the main object of the present invention is to provide surgeons with a disposable and ready-to-use articulated spacing device, able to be directly implanted in the articulation seat for example of knee, hip, hell or elbow joints, in case of replacement of a pre-existing prosthesis which must be removed due to septic or aseptic failures.
  • a further object is to provide a disposable articulated spacing device which allows to maintain a in a healing environment a suitable articular space for the time necessary to successfully re-implant a new permanent prosthesis.
  • a further object is to provide a disposable articulated spacing device which allows correct articulation and an anatomical and ergonomic form of the temporary implant.
  • Yet another object is to provide a disposable articulated spacing device which can be easily implanted and explanted into/from the location of the joint.
  • Yet another object is to provide a disposable articulated spacing device with limited articular friction so as to allow considerable mobility of the joint and improve the quality of life of the patient during hospitalisation.
  • a disposable articulated spacing device for the temporary replacement of a joint of the human body which, in accordance with claim 1 , comprises at least one first member able to be secured to a first articulation end and at least one second member able to be secured to a second a articulation end, both said members being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products, said pre-formed members being able to be reciprocally coupled in an articulated manner to maintain a suitable joint space and at least partial articulated mobility for the time necessary to perform the further implantation of a new permanent joint prosthesis, characterized in that said pre-formed members are initially free of pharmaceutical and therapeutical products, said pre-formed members having a porosity in their base material or suitable cavities formed on their outer surfaces adapted to be filled with pharmaceutical and therapeutical products in the form of liquid solutions added to the pre-formed members immediately prior of implantation thereof either by direct contact and absorption or by insertion thereof in said suitable
  • the above mentioned biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof.
  • the pre-formed members of the device may be previously charged with suitable pharmaceutical and therapeutical products.
  • the pre-formed members are initially free of the same products and are added immediately prior of their implantation by contact absorption or by filling of suitable cavities formed on their other surface.
  • the pharmaceutical and therapeutical products may be chosen among medical active principles, antibiotics and radiopacifier and may be added in the pre-formed members
  • the pre-formed members may comprise a femoral member consisting of a body substantially shell-shaped and reproducing the femoral condyles, and tibial members consisting of a prismatic body able to replace the resected tibial flat portion.
  • FIG. 1 shows a front view of a first detail of a spacing model according to the invention
  • FIG. 2 shows a side view of the detail according to FIG. 1;
  • FIG. 3 shows a top view of the detail according to FIG. 1;
  • FIG. 4 shows a front view of another detail of the spacing device according to the invention.
  • FIG. 5 shows a side view of the detail according to FIG. 4;
  • FIG. 6 shows a top view of the detail according to FIG. 4;
  • FIGS. 7 and 8 show perspective views, from the top and bottom, of the detail of the device illustrated in FIGS. 1 to 3 ;
  • FIGS. 9 and 10 show a side view and a top perspective view of the detail according to FIGS. 4 to 6 ;
  • FIG. 11 shows a perspective view of the two details of the preceding figures in aligned positions.
  • FIG. 12 shows a side view of an alternative embodiment of the spacing device according to the invention.
  • the articulated spacing device generally indicated with the reference number 1 , comprises at least one first member 2 able to be secured to a first joint end and at last one second member 3 able to be secured to a second joint end.
  • both members 2 , 3 are pre-formed and entirely made of a biological compatible and porous material and are mutually coupled in an articulated manner so as to maintain in a healing environment a suitable joint space and at least partial mobility of the joint for the time necessary to permit the further re-implantation of a new permanent joint prosthesis.
  • the biological compatible and porous material may be chosen among metals, metallic alloys organo-metals, ceramics, glasses, plastics materials and combinations thereof.
  • the above plastics material may be chosen among thermoplastic polymers, such as acrylic resins, polyethylene, polypropylene, thermoformable e.g. by blow moulding or injection moulding.
  • the plastics material may be chosen among cold-formable resins curable by means of free radical polymerisation such as acrylic resins and polyesters.
  • free radical polymerisation may be accelerated either by suitable chemical catalysts and initiators, such as benzoyl peroxide, or physical accelerators such as ionizing radiation, gamma-rays, UV-rays.
  • suitable chemical catalysts and initiators such as benzoyl peroxide, or physical accelerators such as ionizing radiation, gamma-rays, UV-rays.
  • the biological compatible and porous material forming the members 2 , 3 is a bone-cements, e.g. that used in the Italian patent application no. VR95A000072 filed by the same applicant.
  • the pre-formed members 2 , 3 may be previously added with suitable pharmaceutical and therapeutical products chosen among active medical principles, antibiotics and radiopacifiers.
  • the pharmaceutical and therapeutical products may be added to the pre-formed members immediately prior of implantation thereof either by direct contact absorption or by filling of suitable cavities formed on their outer surfaces.
  • the pharmaceutical and therapeutical products in the form of liquid solutions may be easily absorbed by the device thanks to the porosity of their basic material and then released after implantation in the joint seat.
  • the pre-formed members 2 , 3 may be shaped in different sizes to be correctly adapted to the different patients. Moreover, these members may present anchoring means for their fixation to the joint ends.
  • the embodiment of the spacer device 1 shown in the figures is designed to be inserted in the knee joint.
  • the pre-formed member 2 is a tibial member and the pre-formed member 3 is a femoral member.
  • the femoral part 3 consists of a first proximal body 4 designed to occupy the space left by an explanted metal prosthesis.
  • the body 4 has a shape, in plan view, approximately in the form of a “U” or horseshoe, with side portions 4 ′, 4 ′′ and a central recess 5 .
  • the external contact surface 6 of the body 4 has a curvature able to reproduce that of the femoral condyles.
  • the tibial member 2 consists of a second proximal body 7 which is approximately prismatic, slightly curved and of suitable thickness.
  • the body 7 also has a shape, in plan view, approximately in the form of a “U” or horseshoe, with a curved internal contact surface 8 and an internal recess 9 so as to simulate the resected tibial flat portion.
  • the contact surfaces 6 , 8 of members 2 , 3 are formed so as to allow a roto-translatory movement during the flexing/extending movement of the limb.
  • the surfaces 6 , 8 may have an excellent surface finish with a low coefficient of friction so as to allow a considerably degree of articular mobility.
  • Both members 2 , 3 may be provided with respective projections or rod-shaped distal portions 10 , 11 for securing to the respective joint ends, e.g. by means of bone cement.
  • the surgeon initially removes the previous infected joint prosthesis and cleans the articulation space.
  • the surgeon further chooses the suitable spacing device with pre-formed members 2 , 3 adapted of the size of the patient.

Abstract

A disposable articulated spacing device for the treatment of joints of the human body, particularly for temporarily replacing an explanted joint prosthesis, comprises at least one first member able to be secured to a first articulation end and at least one second member able to be secured to the other articulation end, both said members being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products. The pre-formed members are reciprocally coupled in an articulated manner to maintain a suitable joint space and at least a partial articulation for the time necessary to perform the further implantation of a joint prosthesis. The biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof. The articulated spacing device maintains a suitable space in the joint seat while allowing considerable articulated mobility, and re-establishes suitable conditions of implantation of a new permanent joint prosthesis.

Description

    DESCRIPTION
  • 1. Technical field [0001]
  • The present invention is generally applicable to surgical treatment of articulations of the human body and in particular relates to a disposable spacing device for temporary replacement of joint prosthesis which have to be explanted due to unsuccessful septic or aseptic implantation of artificial joints. [0002]
  • According to the well known surgical “dual stage” method, the above spacing device can be maintained in the joint seat as long as necessary for reestablishing the most favourable conditions of implantation of the new artificial joint prosthesis. [0003]
  • 2. Background art [0004]
  • It is known how artificial joints, such as knee, hip, heel and elbow joints often have to be removed for various reasons and mainly following local infections after a surgical implant. [0005]
  • In such a case, it is not possible to replace immediately the unsuccessful prosthesis with a new one, but the seat of the joint must be treated with suitable antibiotics before a new surgical operation can be performed. [0006]
  • In the meantime, the space within the joint must be maintained in order to prevent a reduction in the articular space, retraction of-tie tissues, atrophying of the joint and loss of muscular elasticity and tone. [0007]
  • Spacing devices used in the two-stage implant of artificial joints, for treatment of both the hip and the knee, are known. [0008]
  • Italian patent application No. VR95A000072 describes a disposable spacing device for an artificial hip joint, essentially characterized in that it is made of a biocompatible base material of the type used for bone cements. [0009]
  • Spacing devices for knee joints which are manually made by the surgeon at the time of the surgical operation are also known, these devices being made from blocks of bone cement of standard shape, optionally containing active constituents. [0010]
  • A drawback of these known methods of treatment is that they do not allow the space within the joint to be kept apart in an ergonomically and anatomically correct manner. Moreover, the long time required for preparation increases the difficulties for the surgeon and reduces the probability of success of the operation. [0011]
  • In order to overcome these drawbacks, spacing devices have been made using suitable anatomically and ergonomically shaped moulds which are filled with bone cement in situ. However, these known spacing devices do not allow mobilisation of the joint and result in the need for a long rehabilitation after reimplanting the permanent prosthesis. [0012]
  • In still other cases, the spacing devices have been obtained by lining a permanent metal prosthesis with bone cement. Although this solution allows a temporary articulation, it is difficult to prepare and in spite of use of cement-lined prostheses requires that such devices are positioned in infected seats, which most of the surgeon consider a worsening infection factor. [0013]
  • DE-A-29703971 discloses a temporary knee prosthesis comprising three pre-formed members made of bone cement and impregnated with an antibiotic agent, in accordance with the preamble of claim [0014] 1. However, in this prior temporary prosthesis the antibiotic agent is added to the bone cement forming the members during their formation process and therefore the pre-formed members are initially impregnated with such medicaments. Thus, the surgeon has no freedom to choose the specific antibiotic or its amount which are more closely correlated to the particular patient. Moreover, the prosthesis which is not a pharmaceutical product must nevertheless be packaged and stored in a suitable manner to comply with the requirements of the parmaceutical products.
  • U.S. Pat. No. 5,980,573 relates to a temporary hip prosthesis comprising a single pre-formed member failing to provide a complete articulation joint. The base material of the prosthesis is impregnated with an antibiotic agent by simply-mixing it in appropriate amount with the constituent elements of the material during the formation process of the member. Although this prior art document provides that the impregnation of the porous temporary prosthesis may be carried out by soaking it in a liquid antibiotic, it contains no indication that the impregnation may be carried out immediately prior of the implantation of the prosthesis. In both cases, the pre-formed temporary prosthesis is pre-packaged in a sterile packet or container having indicia or colour coding indicating the size of the prosthesis contained therein and the antibiotic concentration, thereby excluding that impregnation is accomplished immediately prior of implantation. [0015]
  • EP-A-0811359 teaches a method for manufacturing a material adapted for use as base material for prostheses, which material is formed by a three dimensional structure of band pieces joined together with the interposition of intermediate removable materials to form adjustable hollow spaces. The hollow spaces of the material may be filled with pharmaceutical or therapeutical active products such as antibiotics, hormones or growing agents. However, there is no indication that such active products may be added or absorbed in the hollow spaces immediately prior of implantation of the prosthesis. [0016]
    • DISCLOSURE OF THE INVENTION
  • The main object of the present invention is to provide surgeons with a disposable and ready-to-use articulated spacing device, able to be directly implanted in the articulation seat for example of knee, hip, hell or elbow joints, in case of replacement of a pre-existing prosthesis which must be removed due to septic or aseptic failures. [0017]
  • A further object is to provide a disposable articulated spacing device which allows to maintain a in a healing environment a suitable articular space for the time necessary to successfully re-implant a new permanent prosthesis. [0018]
  • A further object is to provide a disposable articulated spacing device which allows correct articulation and an anatomical and ergonomic form of the temporary implant. [0019]
  • Yet another object is to provide a disposable articulated spacing device which can be easily implanted and explanted into/from the location of the joint. [0020]
  • Yet another object is to provide a disposable articulated spacing device with limited articular friction so as to allow considerable mobility of the joint and improve the quality of life of the patient during hospitalisation. [0021]
  • These and other objects which will be more apparent hereinafter are achieved by a disposable articulated spacing device for the temporary replacement of a joint of the human body which, in accordance with claim [0022] 1, comprises at least one first member able to be secured to a first articulation end and at least one second member able to be secured to a second a articulation end, both said members being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products, said pre-formed members being able to be reciprocally coupled in an articulated manner to maintain a suitable joint space and at least partial articulated mobility for the time necessary to perform the further implantation of a new permanent joint prosthesis, characterized in that said pre-formed members are initially free of pharmaceutical and therapeutical products, said pre-formed members having a porosity in their base material or suitable cavities formed on their outer surfaces adapted to be filled with pharmaceutical and therapeutical products in the form of liquid solutions added to the pre-formed members immediately prior of implantation thereof either by direct contact and absorption or by insertion thereof in said suitable cavities
  • Preferably, the above mentioned biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof. [0023]
  • The pre-formed members of the device may be previously charged with suitable pharmaceutical and therapeutical products. As alternative, the pre-formed members are initially free of the same products and are added immediately prior of their implantation by contact absorption or by filling of suitable cavities formed on their other surface. [0024]
  • Advantageously, the pharmaceutical and therapeutical products may be chosen among medical active principles, antibiotics and radiopacifier and may be added in the pre-formed members [0025]
  • In case that the articulated spacing device replaces a knee joint, the pre-formed members may comprise a femoral member consisting of a body substantially shell-shaped and reproducing the femoral condyles, and tibial members consisting of a prismatic body able to replace the resected tibial flat portion.[0026]
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • Further features and advantages of the invention will be more clearly understood in the light of the following detailed description of a disposable articulated spacing device furnished by way of a non-limiting example with the aid of the accompanying drawings, in which: [0027]
  • FIG. 1 shows a front view of a first detail of a spacing model according to the invention; [0028]
  • FIG. 2 shows a side view of the detail according to FIG. 1; [0029]
  • FIG. 3 shows a top view of the detail according to FIG. 1; [0030]
  • FIG. 4 shows a front view of another detail of the spacing device according to the invention; [0031]
  • FIG. 5 shows a side view of the detail according to FIG. 4; [0032]
  • FIG. 6 shows a top view of the detail according to FIG. 4; [0033]
  • FIGS. 7 and 8 show perspective views, from the top and bottom, of the detail of the device illustrated in FIGS. [0034] 1 to 3;
  • FIGS. 9 and 10 show a side view and a top perspective view of the detail according to FIGS. [0035] 4 to 6;
  • FIG. 11 shows a perspective view of the two details of the preceding figures in aligned positions; and [0036]
  • FIG. 12 shows a side view of an alternative embodiment of the spacing device according to the invention.[0037]
    • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • With reference to the above mentioned figures, there is shown a disposable articulated spacing device for the temporary replacement of a joint prosthesis explanted from a human body. [0038]
  • The articulated spacing device, generally indicated with the reference number [0039] 1, comprises at least one first member 2 able to be secured to a first joint end and at last one second member 3 able to be secured to a second joint end.
  • According to the invention, both [0040] members 2, 3 are pre-formed and entirely made of a biological compatible and porous material and are mutually coupled in an articulated manner so as to maintain in a healing environment a suitable joint space and at least partial mobility of the joint for the time necessary to permit the further re-implantation of a new permanent joint prosthesis.
  • Preferably, the biological compatible and porous material may be chosen among metals, metallic alloys organo-metals, ceramics, glasses, plastics materials and combinations thereof. [0041]
  • Specifically, the above plastics material may be chosen among thermoplastic polymers, such as acrylic resins, polyethylene, polypropylene, thermoformable e.g. by blow moulding or injection moulding. [0042]
  • As alternative, the plastics material may be chosen among cold-formable resins curable by means of free radical polymerisation such as acrylic resins and polyesters. [0043]
  • In a per se known manner, free radical polymerisation may be accelerated either by suitable chemical catalysts and initiators, such as benzoyl peroxide, or physical accelerators such as ionizing radiation, gamma-rays, UV-rays. [0044]
  • In the particularly preferred embodiment the biological compatible and porous material forming the [0045] members 2, 3 is a bone-cements, e.g. that used in the Italian patent application no. VR95A000072 filed by the same applicant.
  • The [0046] pre-formed members 2, 3 may be previously added with suitable pharmaceutical and therapeutical products chosen among active medical principles, antibiotics and radiopacifiers.
  • In alternative, the pharmaceutical and therapeutical products may be added to the pre-formed members immediately prior of implantation thereof either by direct contact absorption or by filling of suitable cavities formed on their outer surfaces. [0047]
  • The pharmaceutical and therapeutical products in the form of liquid solutions may be easily absorbed by the device thanks to the porosity of their basic material and then released after implantation in the joint seat. [0048]
  • Advantageously, the [0049] pre-formed members 2, 3 may be shaped in different sizes to be correctly adapted to the different patients. Moreover, these members may present anchoring means for their fixation to the joint ends.
  • The embodiment of the spacer device [0050] 1 shown in the figures is designed to be inserted in the knee joint.
  • The [0051] pre-formed member 2 is a tibial member and the pre-formed member 3 is a femoral member.
  • In particular, the [0052] femoral part 3 consists of a first proximal body 4 designed to occupy the space left by an explanted metal prosthesis. Preferably, the body 4 has a shape, in plan view, approximately in the form of a “U” or horseshoe, with side portions 4′, 4″ and a central recess 5. The external contact surface 6 of the body 4 has a curvature able to reproduce that of the femoral condyles.
  • The [0053] tibial member 2 consists of a second proximal body 7 which is approximately prismatic, slightly curved and of suitable thickness. The body 7 also has a shape, in plan view, approximately in the form of a “U” or horseshoe, with a curved internal contact surface 8 and an internal recess 9 so as to simulate the resected tibial flat portion.
  • The contact surfaces [0054] 6, 8 of members 2, 3 are formed so as to allow a roto-translatory movement during the flexing/extending movement of the limb.
  • Moreover, the [0055] surfaces 6, 8 may have an excellent surface finish with a low coefficient of friction so as to allow a considerably degree of articular mobility.
  • Both [0056] members 2, 3 may be provided with respective projections or rod-shaped distal portions 10, 11 for securing to the respective joint ends, e.g. by means of bone cement.
  • In use, the surgeon initially removes the previous infected joint prosthesis and cleans the articulation space. The surgeon further chooses the suitable spacing device with [0057] pre-formed members 2, 3 adapted of the size of the patient.
  • If the pre-formed members are already previously charged with active principles and pharmaceutical and therapeutical products upon formation thereof, the surgeon implants them taking care that they are fixedly secured to the joint ends and are mutually articulately coupled to allow at least partial mobilisation of the joint. [0058]
  • If on the contrary the members are not yet charged as above, the surgeon either impinges them in a solution of active principles or fills with them several outer cavities formed in situ or pre-shaped on their outer surfaces, and finally implants the members in the articulation seat, securing them to the joint ends through appropriate anchoring means or bone cement. [0059]

Claims (14)

1. A disposable articulated spacing device for the treatment of joints of the human body, particularly for temporary replacing an explanted permanent joint prosthesis, comprising at least one first member (2) able to be secured to a first articulation end and at least one second member (3) able to be secured to a second a articulation end, both said members (2,3) being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products, said pre-formed members (2, 3) being able to be reciprocally coupled in an articulated manner to maintain a suitable joint space and at least partial articulated mobility for the time necessary to perform the further implantation of a new permanent joint prosthesis, characterized in that said pre-formed members (2,3) are initially free of pharmaceutical and therapeutical products, said pre-formed members (2, 3) having a porosity in their base material or suitable cavities formed on their outer surfaces adapted to be filled with pharmaceutical and therapeutical products in the form of liquid solutions added to the pre-formed members (2, 3) immediately prior of implantation thereof either by direct contact and absorption or by insertion thereof in said suitable cavities.
2. Spacing device according to claim 1, characterized in that said biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof.
3. Spacing device according to claim 2, characterized in that said plastics material may be chosen among thermoplastic polymers, such as acrylic resins, polyethylene, polypropylene, thermoformable e.g. by blow moulding or injection moulding.
4. Spacing device according to claim 2, characterized in that plastics material are chosen among cold-formable resins.
5. Spacing device according to claim 1, characterized in that said biological compatible and porous material is a bone cement.
6. Spacing device according to claim 1, characterized in that said pharmaceutical and therapeutical products are chosen among active medical principals, antibiotics and radiopacifiers.
7. Spacing device according to claim 1, characterized in that said pre-formed members (2, 3) are configured so as to allow a roto-translatory movement of the condyles during the flexing/extending movement of the limb.
8. Spacing device according to claim 7, characterized in that said pre-formed members (2, 3) have respective contact surfaces (8, 6) with a minimum coefficient of friction so as to allow a high degree of articular mobility.
9. Spacing device according to one or more of the preceding claims, characterized in that said pre-formed members (2, 3) are shaped in different sizes to be adapted to any patients.
10. Spacing device according to claim 1, characterized in that said pre-formed members (2, 3) are provided with anchoring means for attachment thereof to the joint ends.
11. Spacing device according to claim 10, characterized in that said anchoring means consist of respective projections or rod-shaped distal portions (10, 11).
12. Spacing device according to claim 1, characterized in that said pre-formed members (2, 3) are securable to said joint ends with bone cement.
13. Spacing device according to one or more of the preceding claims, particularly for knee joint, characterized in that said pre-formed members (2, 3) comprises a femoral member (3) and a tibial member (2).
14. Spacing device according to claim 13, characterized in that said femoral member (3) consists of a first body (4) substantially in the shape of a shell to reproduce femoral condyles and that said tibial member (2) consists of a second body (7) of substantially prismatic shape with predetermined thickness to replace the resected tibial flat portion.
US10/239,813 2000-04-07 2001-04-09 Disposable articulated spacing device for surgical treatment of joints of the human body Abandoned US20040054417A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/963,123 US7601176B2 (en) 2000-04-07 2004-10-12 Disposable articulated spacing device for surgical treatment of joints of the human body

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITVI2000U000025 2000-04-07
IT2000VI000025U ITVI20000025U1 (en) 2000-04-07 2000-04-07 TEMPORARY SPACER DEVICE FOR SURGICAL TREATMENT OF THE KNEE
PCT/IB2001/000574 WO2001076512A1 (en) 2000-04-07 2001-04-09 Disposable articulated spacing device for surgical treatment of joints of the human body

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/963,123 Continuation US7601176B2 (en) 2000-04-07 2004-10-12 Disposable articulated spacing device for surgical treatment of joints of the human body

Publications (1)

Publication Number Publication Date
US20040054417A1 true US20040054417A1 (en) 2004-03-18

Family

ID=11461146

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/239,813 Abandoned US20040054417A1 (en) 2000-04-07 2001-04-09 Disposable articulated spacing device for surgical treatment of joints of the human body
US10/963,123 Expired - Lifetime US7601176B2 (en) 2000-04-07 2004-10-12 Disposable articulated spacing device for surgical treatment of joints of the human body
US11/029,793 Abandoned US20050119756A1 (en) 2000-04-07 2005-01-05 Disposable articulated spacing device for surgical treatment of joints of the human body

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/963,123 Expired - Lifetime US7601176B2 (en) 2000-04-07 2004-10-12 Disposable articulated spacing device for surgical treatment of joints of the human body
US11/029,793 Abandoned US20050119756A1 (en) 2000-04-07 2005-01-05 Disposable articulated spacing device for surgical treatment of joints of the human body

Country Status (14)

Country Link
US (3) US20040054417A1 (en)
EP (2) EP1274374B1 (en)
JP (2) JP4491181B2 (en)
CN (1) CN1216585C (en)
AT (1) ATE416728T1 (en)
AU (1) AU780792B2 (en)
CA (1) CA2404771C (en)
DE (1) DE60136920D1 (en)
DK (1) DK1274374T3 (en)
ES (1) ES2319100T3 (en)
IT (1) ITVI20000025U1 (en)
MX (1) MXPA02009918A (en)
PT (1) PT1274374E (en)
WO (1) WO2001076512A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070150067A1 (en) * 2005-12-27 2007-06-28 Howmedica Osteonics Corp. Hybrid femoral implant
US20070233266A1 (en) * 2006-03-20 2007-10-04 Howmedica Osteonics Corp. Composite joint implant
US20100102484A1 (en) * 2008-10-29 2010-04-29 Sean Haney Spacer molds with releasable securement
US20100185298A1 (en) * 2009-01-22 2010-07-22 Stone Kenneth D Acetabular Spacer for Treatment of Hip Sepsis
US20100297276A1 (en) * 2007-12-07 2010-11-25 Zimmer, Inc. Spacer Mold and Methods Therefor
US20110118848A1 (en) * 2008-08-06 2011-05-19 Giovanni Faccioli Modular spacer device for the treatment of prosthesis infections
US20130060344A1 (en) * 2011-09-07 2013-03-07 Biomet Manufacturing Corp. Femoral component with reinforced articulating surface
US20140046452A1 (en) * 2012-08-09 2014-02-13 New York University Total knee replacement substituting function of anterior cruciate ligament
US8727203B2 (en) 2010-09-16 2014-05-20 Howmedica Osteonics Corp. Methods for manufacturing porous orthopaedic implants
US20140364954A1 (en) * 2013-06-07 2014-12-11 Gregory Merrell Elbow antibiotic spacer implant
US9622868B2 (en) 2014-04-28 2017-04-18 Biomet Manufacturing, Llc Convertible pre-partial knee replacement
US9622866B2 (en) 2013-03-22 2017-04-18 Heraeus Medical Gmbh Two-component knee spacer with recesses
US10022233B1 (en) * 2017-12-04 2018-07-17 Duke University Orthopedic implant for sustained drug release
US10265179B2 (en) 2013-09-09 2019-04-23 Cossington Limited Adjustable modular spacer device for the articulation of the knee

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448592C (en) 2002-11-08 2011-01-11 Howmedica Osteonics Corp. Laser-produced porous surface
US20060147332A1 (en) * 2004-12-30 2006-07-06 Howmedica Osteonics Corp. Laser-produced porous structure
EP1584308B1 (en) * 2004-03-30 2006-09-13 Fin - Ceramica Faenza S.P.A. A method for the production of a biologically active prosthetic device for the reconstruction of bone tissue and the prosthetic device itself
JP2006015042A (en) * 2004-07-05 2006-01-19 Kazumasa Itokazu Porous ceramic spacer containing medicine
WO2006110896A2 (en) * 2005-04-12 2006-10-19 The University Of Vermont And State Agriculture College Knee prosthesis
US8728387B2 (en) 2005-12-06 2014-05-20 Howmedica Osteonics Corp. Laser-produced porous surface
FR2898039B1 (en) * 2006-03-03 2008-06-27 Ceravic Sas Soc Par Actions Si PROVISIONAL IMPLANT COMPRISING TWO ASSETS.
US7867426B2 (en) * 2006-03-23 2011-01-11 Ziran Bruce H Method of forming a temporary implant
US8147861B2 (en) * 2006-08-15 2012-04-03 Howmedica Osteonics Corp. Antimicrobial implant
WO2009014718A1 (en) 2007-07-24 2009-01-29 Porex Corporation Porous laser sintered articles
US7842095B2 (en) * 2007-09-11 2010-11-30 Howmedica Osteonics Corp. Antibiotic bone cement spacer
US8702801B2 (en) * 2008-02-25 2014-04-22 Linares Medical Devices, Llc Artificial wear resistant plug for mounting to existing joint bone
DE102008040784B3 (en) * 2008-07-28 2009-12-31 Friedrich-Alexander-Universität Erlangen-Nürnberg Femur component for spacer of knee joint of patient, has tibia sided area comprising tibia sided surfaces for cooperating with tibia component of spacer, and clamping mechanism for clamping part of thigh bone
US8454706B2 (en) 2009-02-25 2013-06-04 Brian C. de Beaubien Antibiotic delivery system and method for treating an infected synovial joint during re-implantation of an orthopedic prosthesis
CA2706233C (en) * 2009-06-04 2015-05-05 Howmedica Osteonics Corp. Orthopedic peek-on-polymer bearings
DE202009012964U1 (en) 2009-09-28 2010-03-18 Medizinische Hochschule Hannover - Anstalt des öffentlichen Rechts Casting mold for a cement large head for total hip arthroplasty
US8764840B2 (en) 2010-07-24 2014-07-01 Zimmer, Inc. Tibial prosthesis
CA2806326C (en) 2010-07-24 2020-01-07 Zimmer, Inc. Asymmetric tibial components for a knee prosthesis
EP2613739B1 (en) 2010-09-10 2017-06-07 Zimmer, Inc. Motion facilitating tibial components for a knee prosthesis
US8603101B2 (en) * 2010-12-17 2013-12-10 Zimmer, Inc. Provisional tibial prosthesis system
US9597090B2 (en) 2010-12-17 2017-03-21 Zimmer, Inc. Cut guide attachment for use in tibial prosthesis systems
US9198759B2 (en) 2011-09-19 2015-12-01 Tecres S.P.A. Modular spacer device for the treatment of infections of prosthesis of human limbs
PL2758004T3 (en) * 2011-09-19 2016-03-31 Tecres Spa Temporary modular spacer device for joints of the human body
MX349090B (en) * 2011-09-19 2017-07-10 Tecres Spa Modular spacer device for the treatment of infections of the prosthesis of the human limbs.
US8858643B2 (en) 2011-11-18 2014-10-14 Zimmer, Inc. Tibial bearing component for a knee prosthesis with improved articular characteristics
ES2585838T3 (en) 2011-11-21 2016-10-10 Zimmer, Inc. Tibial base plate with asymmetric placement of fixing structures
CA2863375C (en) 2012-01-30 2019-07-16 Mary S.S. Wentorf Asymmetric tibial components for a knee prosthesis
US9364896B2 (en) 2012-02-07 2016-06-14 Medical Modeling Inc. Fabrication of hybrid solid-porous medical implantable devices with electron beam melting technology
US9135374B2 (en) 2012-04-06 2015-09-15 Howmedica Osteonics Corp. Surface modified unit cell lattice structures for optimized secure freeform fabrication
US9180010B2 (en) 2012-04-06 2015-11-10 Howmedica Osteonics Corp. Surface modified unit cell lattice structures for optimized secure freeform fabrication
FR2989568B1 (en) * 2012-04-19 2014-09-05 Teknimed IMPLANT SPACER FOR TEMPORARY REPLACEMENT OF KNEE PROSTHESIS
DE102013011296A1 (en) 2013-07-08 2015-01-08 Heraeus Medical Gmbh Two-part articulating joint spacer and method for its production
DE102013213831B4 (en) * 2013-07-15 2015-01-29 Heraeus Medical Gmbh Knee spacer for temporary replacement of an artificial knee joint
US9925052B2 (en) 2013-08-30 2018-03-27 Zimmer, Inc. Method for optimizing implant designs
ES2735730T3 (en) * 2014-09-23 2019-12-20 Tecres Spa Constrained prosthesis for the knee joint
US20170340445A1 (en) * 2014-12-05 2017-11-30 Ceramtec Gmbh Ceramic Spacer for the Two-Sided Replacement of Implants in Shoulder, Knee and Hip as a Result of Infections
FR3032347B1 (en) 2015-02-05 2019-12-20 Assistance Publique - Hopitaux De Paris TOTAL KNEE PROSTHESIS WITH CERAMIC FRICTION TORQUE ON CERAMIC AND MOBILE CERAMIC TRAY.
US10433965B2 (en) 2015-06-17 2019-10-08 Joint Purification Systems Llc Total joint replacement infection control devices and methods
WO2017053196A1 (en) 2015-09-21 2017-03-30 Zimmer, Inc. Prosthesis system including tibial bearing component
EP3359093B1 (en) 2015-10-07 2019-12-11 CeramTec GmbH Knee endoprosthesis for the replacement of at least part of the knee joint
CN110402123B (en) 2017-03-10 2022-02-08 捷迈有限公司 Tibial prosthesis with tibial bearing component fastening features
CN110636818B (en) 2017-05-12 2021-06-04 捷迈有限公司 Femoral prosthesis with size augmentation and size reduction capabilities
US11298747B2 (en) 2017-05-18 2022-04-12 Howmedica Osteonics Corp. High fatigue strength porous structure
US11426282B2 (en) 2017-11-16 2022-08-30 Zimmer, Inc. Implants for adding joint inclination to a knee arthroplasty
US10835380B2 (en) 2018-04-30 2020-11-17 Zimmer, Inc. Posterior stabilized prosthesis system
IT201900012372A1 (en) 2019-07-19 2021-01-19 Tecres Spa SPACER DEVICE FOR THE CONTROL OF DISORDERS OR INFECTIONS
CN110721337A (en) * 2019-10-12 2020-01-24 上海交通大学医学院附属第九人民医院 Application of zinc-based alloy material, joint open prosthesis and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462120A (en) * 1981-07-06 1984-07-31 Andre Rambert Total knee prosthesis
US5123927A (en) * 1990-12-05 1992-06-23 University Of British Columbia Method and apparatus for antibiotic knee prothesis
US6027743A (en) * 1994-06-03 2000-02-22 Stryker Corporation Manufacture of autogenous replacement body parts
US6113640A (en) * 1997-06-11 2000-09-05 Bionx Implants Oy Reconstructive bioabsorbable joint prosthesis
US20010018614A1 (en) * 1999-03-16 2001-08-30 Bianchi John R. Implants for orthopedic applications
US20030033021A1 (en) * 2001-07-16 2003-02-13 Plouhar Pamela Lynn Cartilage repair and regeneration scaffold and method

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133755A (en) * 1986-01-28 1992-07-28 Thm Biomedical, Inc. Method and apparatus for diodegradable, osteogenic, bone graft substitute device
DE4033291A1 (en) * 1990-10-19 1992-04-23 Draenert Klaus MATERIAL AND METHOD FOR THE PRODUCTION THEREOF
EP0523926A3 (en) * 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
US5344459A (en) * 1991-12-03 1994-09-06 Swartz Stephen J Arthroscopically implantable prosthesis
DE4242889A1 (en) * 1992-12-18 1994-06-23 Merck Patent Gmbh Hollow endoprostheses with filling that promotes bone growth
US5522895A (en) * 1993-07-23 1996-06-04 Rice University Biodegradable bone templates
JP3333211B2 (en) * 1994-01-26 2002-10-15 レイリー，マーク・エイ Improved expandable device for use in a surgical method for bone treatment
US5947893A (en) * 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
EP0700671B1 (en) * 1994-09-08 2001-08-08 Stryker Technologies Corporation Hydrogel intervertebral disc nucleus
DE4435680A1 (en) * 1994-10-06 1996-04-11 Merck Patent Gmbh Porous bone substitute materials
CA2160198C (en) * 1994-10-27 2003-12-30 Michael J. Pappas Prosthesis fixturing device
US5702458A (en) * 1994-12-09 1997-12-30 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Joint prosthesis
FI101933B1 (en) * 1995-06-13 1998-09-30 Biocon Oy A joint prosthesis
JPH0930988A (en) * 1995-07-21 1997-02-04 Sumitomo Osaka Cement Co Ltd Sustained release porous ceramic molding for medicine and its production
IT1278853B1 (en) 1995-09-08 1997-11-28 Tecres Spa DISPOSABLE SPACER DEVICE FOR THE TREATMENT OF HIP PROSTHESES
AU5596898A (en) * 1996-12-03 1998-06-29 Osteobiologics, Inc. Biodegradable polymeric film
DE29703971U1 (en) * 1997-03-05 1998-07-09 Siebel Thomas Dr Bone prosthesis
EP0984795B1 (en) * 1997-04-22 2003-09-24 Washington Research Foundation Bone grafts and prostheses coated with tartrate-resistant acid phosphatase
US5980573A (en) * 1997-05-12 1999-11-09 Shaffner; Richard L. Method and apparatus for fighting infection and maintaining joint spacing in a prosthesis implant area
US6410044B1 (en) * 1998-03-19 2002-06-25 Surmodics, Inc. Crosslinkable macromers
US6129757A (en) * 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
US6398814B1 (en) * 1998-09-14 2002-06-04 Bionx Implants Oy Bioabsorbable two-dimensional multi-layer composite device and a method of manufacturing same
US6419709B1 (en) * 1998-10-02 2002-07-16 Guilford Pharmaceuticals, Inc. Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
US6454811B1 (en) * 1998-10-12 2002-09-24 Massachusetts Institute Of Technology Composites for tissue regeneration and methods of manufacture thereof
US20030114936A1 (en) * 1998-10-12 2003-06-19 Therics, Inc. Complex three-dimensional composite scaffold resistant to delimination
US6328765B1 (en) * 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6206927B1 (en) * 1999-04-02 2001-03-27 Barry M. Fell Surgically implantable knee prothesis
US7338524B2 (en) * 1999-05-10 2008-03-04 Fell Barry M Surgically implantable knee prosthesis
US6419704B1 (en) * 1999-10-08 2002-07-16 Bret Ferree Artificial intervertebral disc replacement methods and apparatus
JP4172883B2 (en) * 1999-09-08 2008-10-29 Ｈｏｙａ株式会社 Drug sustained release carrier and method for producing drug sustained release carrier
WO2002016589A2 (en) * 2000-08-21 2002-02-28 Millennium Pharmaceuticals, Inc. Human abc transporter family member and uses thereof
DK177997B1 (en) * 2000-07-19 2015-02-23 Ed Geistlich Söhne Ag Für Chemische Ind Bone material and collagen combination for healing of damaged joints
JP4412901B2 (en) * 2001-03-02 2010-02-10 ウッドウェルディング・アクチェンゲゼルシャフト Implants for making connections to tissue parts, in particular skeletal parts, and devices and methods for implantation of implants

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462120A (en) * 1981-07-06 1984-07-31 Andre Rambert Total knee prosthesis
US5123927A (en) * 1990-12-05 1992-06-23 University Of British Columbia Method and apparatus for antibiotic knee prothesis
US6027743A (en) * 1994-06-03 2000-02-22 Stryker Corporation Manufacture of autogenous replacement body parts
US6113640A (en) * 1997-06-11 2000-09-05 Bionx Implants Oy Reconstructive bioabsorbable joint prosthesis
US20010018614A1 (en) * 1999-03-16 2001-08-30 Bianchi John R. Implants for orthopedic applications
US20030033021A1 (en) * 2001-07-16 2003-02-13 Plouhar Pamela Lynn Cartilage repair and regeneration scaffold and method

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070150067A1 (en) * 2005-12-27 2007-06-28 Howmedica Osteonics Corp. Hybrid femoral implant
US8070821B2 (en) 2005-12-27 2011-12-06 Howmedica Osteonics Corp. Hybrid femoral implant
US8333805B2 (en) 2006-03-20 2012-12-18 Howmedica Osteonics Corp. Composite joint implant
US20070233266A1 (en) * 2006-03-20 2007-10-04 Howmedica Osteonics Corp. Composite joint implant
US8801983B2 (en) 2007-12-07 2014-08-12 Zimmer Orthopaedic Surgical Products, Inc. Spacer mold and methods therefor
US20100297276A1 (en) * 2007-12-07 2010-11-25 Zimmer, Inc. Spacer Mold and Methods Therefor
US8480389B2 (en) 2007-12-07 2013-07-09 Zimmer Orthopedic Surgical Products, Inc. Spacer mold and methods therefor
US20150351919A1 (en) * 2008-08-06 2015-12-10 Tecres S.P.A. Modular spacer device for the treatment of prosthesis infections
US20110118848A1 (en) * 2008-08-06 2011-05-19 Giovanni Faccioli Modular spacer device for the treatment of prosthesis infections
US9795486B2 (en) * 2008-08-06 2017-10-24 Tecres S.P.A. Modular spacer device for the treatment of prosthesis infections
US9173742B2 (en) * 2008-08-06 2015-11-03 Tecres S.P.A. Modular spacer device for the treatment of prosthesis infections
US20100102484A1 (en) * 2008-10-29 2010-04-29 Sean Haney Spacer molds with releasable securement
US8414286B2 (en) 2008-10-29 2013-04-09 Zimmer Orthopaedic Surgical Products, Inc. Spacer molds with releasable securement
US10471638B2 (en) 2008-10-29 2019-11-12 Zimmer Orthopedic Surgical Products, Inc. Spacer molds with releasable securement
US8899959B2 (en) 2008-10-29 2014-12-02 Zimmer Orthopaedic Surgical Products, Inc. Spacer molds with releasable securement
US20100185298A1 (en) * 2009-01-22 2010-07-22 Stone Kenneth D Acetabular Spacer for Treatment of Hip Sepsis
US8727203B2 (en) 2010-09-16 2014-05-20 Howmedica Osteonics Corp. Methods for manufacturing porous orthopaedic implants
US20130060344A1 (en) * 2011-09-07 2013-03-07 Biomet Manufacturing Corp. Femoral component with reinforced articulating surface
US9023111B2 (en) * 2012-08-09 2015-05-05 New York University Total knee replacement substituting function of anterior cruciate ligament
US20140046452A1 (en) * 2012-08-09 2014-02-13 New York University Total knee replacement substituting function of anterior cruciate ligament
US9622866B2 (en) 2013-03-22 2017-04-18 Heraeus Medical Gmbh Two-component knee spacer with recesses
US9278002B2 (en) * 2013-06-07 2016-03-08 Gregory Merrell Elbow antibiotic spacer implant
US20140364954A1 (en) * 2013-06-07 2014-12-11 Gregory Merrell Elbow antibiotic spacer implant
US10265179B2 (en) 2013-09-09 2019-04-23 Cossington Limited Adjustable modular spacer device for the articulation of the knee
US9622868B2 (en) 2014-04-28 2017-04-18 Biomet Manufacturing, Llc Convertible pre-partial knee replacement
US10350076B2 (en) 2014-04-28 2019-07-16 Biomet Manufacturing, Llc Convertible pre-partial knee replacement
US10022233B1 (en) * 2017-12-04 2018-07-17 Duke University Orthopedic implant for sustained drug release

Also Published As

Publication number Publication date
US20050085918A1 (en) 2005-04-21
PT1274374E (en) 2009-03-16
EP1952787A1 (en) 2008-08-06
ITVI20000025U1 (en) 2001-10-07
EP1274374A1 (en) 2003-01-15
ATE416728T1 (en) 2008-12-15
CN1440262A (en) 2003-09-03
JP4491181B2 (en) 2010-06-30
JP5156727B2 (en) 2013-03-06
US7601176B2 (en) 2009-10-13
AU780792B2 (en) 2005-04-14
US20050119756A1 (en) 2005-06-02
CA2404771A1 (en) 2001-10-18
JP2003529440A (en) 2003-10-07
WO2001076512A1 (en) 2001-10-18
CA2404771C (en) 2009-09-01
DE60136920D1 (en) 2009-01-22
JP2010088921A (en) 2010-04-22
CN1216585C (en) 2005-08-31
DK1274374T3 (en) 2009-04-14
AU4675201A (en) 2001-10-23
ES2319100T3 (en) 2009-05-04
EP1274374B1 (en) 2008-12-10
MXPA02009918A (en) 2004-09-06

Similar Documents

Publication Publication Date Title
CA2404771C (en) Disposable articulated spacing device for surgical treatment of joints of the human body
US7427296B2 (en) Total knee joint mold and methods
US7429346B2 (en) Method of forming a temporary prosthetic joint using a disposable mold
US8388881B2 (en) Method forming a one-piece articulating spacing device for a knee joint
KR102461337B1 (en) Improved adjustable modular spacer device for the articulation of the knee
CA2545515A1 (en) Tissue integration design for seamless implant fixation
CN105636553B (en) For kneed adjustable modularization spacer device
US5980573A (en) Method and apparatus for fighting infection and maintaining joint spacing in a prosthesis implant area
Schoellner et al. Individual bone cement spacers (IBCS) for septic hip revision—preliminary report
CN103841923A (en) Temporary modular spacer device for joints of the human body
CN111867520A (en) Temporary spacer device for human body joints
CN109640890B (en) Modular spacer device for joints of the human body
RU174697U1 (en) HIP JOINT SPACER
CN212186772U (en) Movable space occupying device
US11951012B2 (en) Femoral element of knee spacer
US11344419B1 (en) Total knee joint mold and methods for gap balancing and joint line restoration
CN214761627U (en) Scaphoid core type prosthesis made of metal tantalum with good mechanical property
RU146653U1 (en) FORM FOR INTRAOPERATIVE MANUFACTURE OF THE SURFACE COMPONENT OF THE SPACER OF THE HIP JOINT
RU2249438C1 (en) Method for making bone defect plastic repair
CN111214314A (en) Movable space occupying device
JP2023139443A (en) Structure of artificial hip joint stem and production method

Legal Events

Date Code Title Description
AS Assignment

Owner name: TECRES S.P.A., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SOFFIATI, RENZO;CASTELLI, CLAUDIO;FACCIOLI,GIOVANNI;REEL/FRAME:013179/0937

Effective date: 20021014

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION